Extending the time window for endovascular procedures according to collateral pial circulation

Stroke

Volumn 42, Issue 12, 2011, Pages 3465-3469

  Ribo, Marc ^a   Flores, Alan ^a   Rubiera, Marta ^a   Pagola, Jorge ^a   Sargento Freitas, Joao ^b   Rodriguez Luna, David ^a   Coscojuela, Pilar ^a   Maisterra, Olga ^a   Piñeiro, Socorro ^a   Romero, Francisco J ^a   Alvarez Sabin, Jose ^a   Molina, Carlos A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Collateral flow; Intra arterial; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PIA ARTERY; PREDICTOR VARIABLE; PRIORITY JOURNAL; STROKE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COLLATERAL CIRCULATION; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856212817     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.623827     Document Type: Article

References (20)

1. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127-2135.
2. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205-1212. (Pubitemid 351440692)
3. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761-2768.
4. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke. 2010;41:1996-2000.
5. Chang KC, Hsu SW, Liou CW, Huang YC, Lee LH, Lui CC, et al. Intra-arterial thrombolytic therapy for acute intracranial large artery occlusive disease in patients selected by magnetic resonance image. J Neurol Sci. 2010;297:46-51.
6. Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2005;26:1789-1797. (Pubitemid 43853681)
7. Mohammad Y, Xavier AR, Christoforidis G, Bourekas E, Slivka A. Qureshi grading scheme for angiographic occlusions strongly correlates with the initial severity and in-hospital outcome of acute ischemic stroke. J Neuroimaging. 2004;14:235-241. (Pubitemid 38781394)
8. Mohammad YM, Christoforidis GA, Bourekas EC, Slivka AP. Qureshi grading scheme predicts subsequent volume of brain infarction following intra-arterial thrombolysis in patients with acute anterior circulation ischemic stroke. J Neuroimaging. 2008;18:262-267.
9. Christoforidis GA, Karakasis C, Mohammad Y, Caragine LP, Yang M, Slivka AP. Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol. 2009;30:165-170.
10. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke. 2011;42:693-699.
11. Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32:1079-1084. (Pubitemid 32825786)
12. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674. (Pubitemid 30248478)
13. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109-e137.
14. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase Clinical findings through hospital discharge. Circulation. 1987;76:142-154. (Pubitemid 17093202)
15. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
16. Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol. 2006;27:1612-1616. (Pubitemid 44413533)
17. van der Worp HB, Claus SP, Bar PR, Ramos LM, Algra A, van Gijn J, et al. Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke. 2001;32:424-430. (Pubitemid 32155229)
18. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
19. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group. Stroke. 1988;19:512-517.
20. Emery DJ, Schellinger PD, Selchen D, Douen AG, Chan R, Shuaib A, et al. Safety and feasibility of collateral blood flow augmentation after intravenous thrombolysis. Stroke. 2011;42:1135-1137.